You searched for "radiotherapy"
Comparison of pathological stage in patients treated with and without neoadjuvant chemotherapy for high-risk UTUC
1 March 2019
| Zeeshan Aslam
|
URO - Urologic Oncology
High-risk upper tract urothelial carcinoma (UTUC) has been associated with poor survival outcomes. The authors evaluated the role of neoadjuvant chemotherapy in high-risk cases prior to radical nephroureterectomy (RNU) in terms of pathological stage of the final surgical specimen. A...
Management of Prostate Cancer: A Multidisciplinary Approach
4 September 2020
| Jay Khastgir
|
URO - Urologic Oncology
This is an excellent textbook which comprehensively covers the vast field of prostate cancer. The editors, who have co-ordinated phase III European Organisation for Research and Treatment of Cancer (EORTC) trials, have brought together a large array of well-known international...
One cycle of adjuvant chemotherapy in tumours of the testis
4 May 2020
| Sana J Khan
|
URO - Urologic Oncology
Following a radical orchiectomy, current UK practice for newly diagnosed, high-risk, stage 1 nonseminomatous or combined germ cell tumours of the testis (NSCGCTT) is either two cycles of adjuvant chemotherapy with bleomycin, etoposide, cisplatin (BE360Px2) or surveillance with BE500Px3 on...
Prostate cancer
8 November 2021
| Conor Devlin, Marcelino Yazbek Hanna
|
URO - Urologic Oncology
Case 1 A 65-year-old man is referred to your two-week wait (2WW) clinic with a PSA of 7.0ng/mL. He has no lower urinary tract symptoms (LUTS), no past medical history, no family history of prostate cancer (PCa) and his performance...
Demanding cases or nightmares in uro-oncology? Jan/Feb 2023
6 January 2023
| Jonathan Noël, Ata Jaffer, Ben Challacombe
|
URO - Urologic Oncology
Radical surgical treatment of prostate cancer has become minimally invasive owing to robotic assisted laparoscopic technology [1]. Patients who undergo robotic assisted radical prostatectomy (RARP) often have lower risk of morbidity compared to an open approach. However, patients with a...
Metabolic syndrome and prostate cancer recurrence in a veterans’ cohort
1 November 2015
| Pravisha Ravindra
|
URO - Urologic Oncology
This study explored the relationship between metabolic syndrome and localised prostate cancer recurrence in patients who had received active treatment (external beam radiation therapy – EBRT, radical retropubic prostatectomy – RRP, or brachytherapy). The definition of metabolic syndrome adopted was...
Using cryopreserved prepubertal testis tissues – are we getting warmer?
12 September 2023
| Michael P Rimmer, Kathleen Duffin, Rod T Mitchell
|
URO - Andrology, URO - Basic Science Research, URO - Urologic Oncology
The rising incidence of childhood cancer coupled with increasing survivorship means there is a growing population of childhood cancer survivors with unmet health needs. In the UK around 1 in 500 children and young people are survivors of childhood cancer....
Male urethrograms
1 January 2016
| Cairine Probert
An ascending urethrogram is the best initial radiographic technique to image a male patient’s urethra and is indicated for strictures, fistulae, trauma and urethral obstruction [1]. It is quick and straightforward to perform and is performed using an 8Fr Foley...
Management of stage 1 non-seminomatous germ cell tumours
1 November 2014
| Karen De Souza, Alexandra Dudek, Simon Chowdhury
|
URO - Urologic Oncology
Testicular cancer (TC) is the most successfully treated solid tumour, achieving a cure rate of 90-95% [1-3]. Testicular cancer is relatively rare with an incidence of 2207 cases in the UK in 2014 [4] and yet is the most common...
Early British pioneers of urological imaging
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In this article I am joined by Gavin Gordon of Newcastle University whose...Sexual dysfunction following prostate cancer treatment
4 March 2024
| Maria Harrington-Vogt, Aditya Manjunath, Nader Gaballa, Odunayo M Kalejaiye
|
URO - Andrology, URO - Urologic Oncology
Prostate cancer is common with over 52,300 new cases diagnosed annually in the UK; this is expected to rise by 15% between 2023-2025 and 2038-2040 [1]. Radical prostatectomy continues to be the most common form of radical treatment for men...
Post-prostatectomy incontinence
4 May 2020
| Alison Downey, Ian Beckley
|
URO - Functional / Reconstructive Urology, URO - Urologic Oncology
Urinary incontinence following prostate surgery (post-prostatectomy incontinence or PPI) is a significant complication that can have a profoundly negative impact on the quality of life of patients suffering with it. It may become a barrier to physical activity and social...
